Maxwell R. Lloyd MD

Maxwell Lloyd, MD, is a clinical fellow in hematology and medical oncology at Beth Israel Deaconess Medical Center. His career interests have been shaped by his research experiences in breast cancer over the past ten years.

During this time, Dr. Lloyd's efforts have been tailored toward clinical and translational projects in metastatic breast cancer and personalized medicine. This research has focused on investigating biomarkers of drug response to CDK4/6 inhibitors and endocrine-based therapies in patients with hormone receptor-positive advanced breast cancer. The goal of his work has been to characterize novel tumor susceptibilities and guide the development of precision-based treatment strategies.

Dr. Lloyd's hope is that tailoring therapies based on underlying tumor biology will improve clinical outcomes and help address overtreatment for individual patients. Precision-guided cancer care is an area of investigation that I am passionate about, and which has tremendous potential to increase clinical benefit while minimizing toxicity.